ML18068A037

Capital Cardiology, P.C. (2/28/18) - NRC Form 591M Parts 1 & 3, Inspection Report 03037572/2018001 (DNMS)

ML18068A037
Person / Time
Site:	03037572
Issue date:	02/28/2018
From:	Geoffrey Warren NRC/RGN-III
To:	Kritzman M Capital Cardiology, PC
References
IR 2018001
Download: ML18068A037 (2)

See also: IR 07200201/1980001

Text

NRC FORM 591M PART 1

U.S. NUCLEAR REGULATORY COMMISSION

(07-2012)

1ocFR2.201

SAFETY INSPECTION REPORT AND COMPLIANCE INSPECTION

1. LICENSEE/LOCATION INSPECTED:

Capital Cardiology, P.C.

1200 E. Michigan Ave.

Lansing, Michigan 48912

REPORT NUMBER(S) 2018001

3. DOCKET NUMBER(S)

030-37572

LICENSEE:

2. NRC/REGIONAL OFFICE

Region III

U. S. Nuclear Regulatory Commission

2443 Warrenville Road, Suite 210

Lisle, IL 60532-4352

4. LICENSE NUMBER(S)

5. DATE(S) OF INSPECTION

21-32677-01

The inspection was an examination of the activities conducted under your license as they relate to radiation safety and to compliance with the Nuclear

Regulatory Commission (NRC) rules and regulations and the conditions of your license. The inspection consisted of selective examinations of

procedures and representative records, interviews with personnel, and observations by the inspector. The inspection findings are as follows:

~

Based on the inspection findings, no violations were identified.

D 2.

Previous violation(s) closed.

D 3.

D4.

The violations(s), specifically described to you by the inspector as non-cited violations, are not being cited because they were self-identified,

non-repetitive, and corrective action was or is being taken, and the remaining criteria in the NRC Enforcement Policy, to exercise

discretiol), were satisfied.

Non-cited violation(s) were discussed involving the following requirement(s):

During this inspection, certain of your activities, as described below and/or attached, were in violation of NRC requirements and are being

cited in accordance with NRC Enforcement Policy. This form is a NOTICE OF VIOLATION, which may be subject to posting in accordance

with 10 CFR 19.11.

(Violations and Corrective Actions)

Statement of Corrective Actions

I hereby state that, within 30 days, the actions described by me to the Inspector will be taken to correct the violations identified. This statement of

corrective actions is made in accordance with the requirements of 10 CFR 2.201 (corrective steps already taken, corrective steps which will be taken,

date when full compliance will be achieved). I understand that no further written response to NRC will be required, unless specifically requested.

TITLE

PRINTED NAME

SIGNATURE

DATE

LICENSEE'S

REPRESENTATIVE

NRC INSPECTOR

Geoffrey Warren, Sr. HP

BRANCH CHIEF

Aaron Mccraw

NRC FORM 591M PART 1 (07-2012)

hV-

NRC FORM 591M PART 3

(07-2012)

10 CFR 2.201

U.S. NUCLEAR REGULATORY COMMISSION

Docket File Information

SAFETY INSPECTION REPORT AND COMPLIANCE INSPECTION

1. LICENSEE/LOCATION INSPECTED:

Capital Cardiology, P.C.

1200 E. Michigan Ave.

Lansing, Michigan 48912

REPORT NUMBER(S) 2018001

3. DOCKET NUMBER(S)

030-37572

6. INSPECTION PROCEDURES USED

87130

2. NRG/REGIONAL OFFICE

Region III

U. S. Nuclear Regulatory Commission

2443 Warrenville Road, Suite 210

Lisle, IL 60532:.4352

4. LICENSE NUMBER(S)

21-32677-01

7. INSPECTION FOCUS AREAS

03.01 - 03.09

5. DATE(S) OF INSPECTION

February 28, 2018

SUPPLEMENTAL INSPECTION INFORMATION

1. PROGRAM CODE(S)

02201

2. PRIORITY

5

I{] Main Office Inspection

D Field Office Inspection

D Temporary Job Site Inspection

3. LICENSEE CONTACT

4. TELEPHONE NUMBER

Michelle Kritzman, M.S., RSO

(734) 637-2408

Next Inspection Date:

02/28/2023

PROGRAM SCOPE

This was an unannounced routine inspection. The licensee was a cardiology clinic located in Lansing, Michigan, with

authorization to use byproduct materials in 10 CPR 35.200 only. The nuclear medicine department was staffed with one

full-time nuclear medicine technologist, who typically administered 120 diagnostic doses monthly, limited to cardiac

stress tests. The department received unit doses as needed from a licensed nuclear pharmacy. All waste was either held

for decay-in-storage (DIS) or returned to the nuclear pharmacy.

Performance Observations: The inspector observed one diagnostic administration of licensed materials, including dose

preparation and disposal. The technologist demonstrated survey meter and wipe counter QC, dose calibrator constancy,

package receipt surveys and wipes, daily and weekly contamination surveys, and other procedures. The inspector noted

no concerns with these activities. Review of dosimetry records indicated no exposures of regulatory concern. Interviews

with licensee personnel indicated adequate knowledge of radiation safety concepts and procedures. The inspector

performed independent and confirmatory radiation measurements which indicated results consistent with licensee survey

records and postings.

No violations were identified during this inspection.

NRG FORM 591M PART 3 (07-2012)